Target intelligence / Profile preview

Manganese(II), Cadmium(II), and Aluminum(III) ions (Mn2+, Cd2+, Al3+)

Target
Mn2+, Cd2+, Al3+
Molecular classification
Other
01

Overview

Manganese(II), Cadmium(II), and Aluminum(III) are inorganic metal cations with distinct biological and toxicological profiles. Manganese (Mn2+) is an essential trace element required for the function of various enzymes, including manganese superoxide dismutase and arginase, but chronic overexposure can lead to a neurodegenerative condition known as manganism (Source: PubChem CID 23930; StatPearls, Manganese Toxicity). Cadmium (Cd2+) is a highly toxic heavy metal with no known biological role in humans; it acts as a cumulative toxin affecting the kidneys and skeletal system and is classified as a human carcinogen (Source: ATSDR, Toxicological Profile for Cadmium). Aluminum (Al3+) is a non-essential metal that can exert neurotoxic effects and interfere with bone mineralization, particularly in patients with impaired renal function (Source: NIH, Aluminum Toxicity). These ions are not therapeutic targets in the conventional sense but are instead subjects of toxicological concern or act as cofactors/inhibitors for various proteins. Pharmacological intervention typically involves the use of chelating agents to facilitate their removal from the body (Source: StatPearls, Chelating Agents). Because this entry combines three distinct chemical species with different biological profiles, it does not represent a single canonical therapeutic target.

Other names
Manganese cationCadmium cationAluminum cationMn(II)Cd(II)Al(III)Heavy metal ions
02

Mechanism of action

Chelation therapy involves the administration of ligands that bind to these metal ions to form stable, water-soluble complexes that are subsequently excreted by the kidneys.

03

Biological functions

Other
04

Disease associations

Neurodegenerative diseaseOther
05

Safety considerations

NeurotoxicityNephrotoxicityOsteomalaciaDepletion of essential trace elements during chelation
06

Interacting drugs

Edetate calcium disodium

4 more in the full profile.

07

Biomarkers

Blood manganese levelsUrinary cadmium levelsSerum aluminum levelsUrinary beta-2 microglobulin

Beyond the preview

Go deeper on Manganese(II), Cadmium(II), and Aluminum(III) ions (Mn2+, Cd2+, Al3+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Manganese(II), Cadmium(II), and Aluminum(III) ions (Mn2+, Cd2+, Al3+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call